Group Leader
Antonio Gil Moreno
Principal Investigator (PI)
Antonio Gil Moreno, Eva Colás Ortega, Silvia Cabrera Díaz, Melissa Bradbury
Researchers
Cristian Moiola, Javier de la Torre, Martín Espinosa, JL Poza, Assumpció Pérez Benavente, Cristina Centeno, Martina Angeles Fité, Jose Luís Sánchez, Vicente Bebia, Anna Luzarraga, Laura Mañalich, Elena Suárez, Montse Cubo, Sonia Monreal, Diana Guerrero, Ursula Acosta, Josep Castellví, Angel García, Carme Dinarés, Anna Ruano, Sabina Salicrú, Christian Sisó
PhD Students
Carina Masferrer, Taya Melnychuk, Eva Coll, Carlos López, Beatriz Villafranca, Armando Reques, Melek Denizli, Irene de la Calle
Lab Technicians
Marta Rebull
Nursing and Technical Staff
Elisabet Olivan
39
PUBLICATIONS
71.8%
%Q1
442
IMPACT FACTOR
11.33
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
Vrede SW, Kasius J, Bulten J, Teerenstra S, Huvila J, Colas E, Gil-Moreno A, Boll D, Vos MC, van Altena AM, Asberger J, Sweegers S, van Weelden WJ, van der Putten LJM, Amant F, Visser NCM, Snijders MPLM, Küsters-Vandevelde HVN, Kruitwagen R, Matias-Guiu X, Weinberger V, Reijnen C, Pijnenborg JMA.
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.
JAMA Netw Open . 2022 Dec 1;5(12):e2247372
DOI: doi: 10.1001/jamanetworkopen.2022.47372
IF: 13.353
Villafranca-Magdalena B, Masferrer-Ferragutcasas C, Lopez-Gil C, Coll-de la Rubia E, Rebull M, Parra G, García Á, Reques A, Cabrera S, Colas E, Gil-Moreno A*, Moiola CP
Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool.
Int J Mol Sci . 2022 Jun 3;23(11):6266
DOI: doi: 10.3390/ijms23116266
IF: 6.208
Díaz-Feijoó B, Acosta Ú, Torné A, Gil-Ibáñez B, Hernández A, Domingo S, Bradbury M, Gil-Moreno A
Surgical Outcomes of Laparoscopic Pelvic Lymph Node Debulking during Staging Aortic Lymphadenectomy in Locally Advanced Cervical Cancer: A Multicenter Study.
Cancers (Basel) . 2022 Apr 13;14(8):1974
DOI: doi: 10.3390/cancers14081974
IF: 6.575
Mota A, Oltra SS, Selenica P, Moiola CP, Casas-Arozamena C, López-Gil C, Diaz E, Gatius S, Ruiz-Miro M, Calvo A, Rojo-Sebastián A, Hurtado P, Piñeiro R, Colas E, Gil-Moreno A, Reis-Filho JS, Muinelo-Romay L, Abal M, Matias-Guiu X, Weigelt B, Moreno-Bueno G
Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression.
Oncogene . 2022 Mar;41(13):1835-1850
DOI: doi: 10.1038/s41388-022-02221-0
IF: 8.756
Fernandez-Gonzalez S, Ponce J, Martínez-Maestre MÁ, Barahona M, Gómez-Hidalgo NR, Díaz-Feijoo B, Casajuana A, Gracia M, Frias-Gomez J, Benavente Y, Costas L, Martí L, Melero L, Silvan JM, Beiro E, Lobo I, De la Rosa J, Coronado PJ, Gil-Moreno A
The Impact of Surgical Practice on Oncological Outcomes in Robot-Assisted Radical Hysterectomy for Early-Stage Cervical Cancer, Spanish National Registry
Cancers (Basel) . 2022 Jan 29;14(3):698
DOI: doi: 10.3390/cancers14030698
IF: 6.575
WOMEC ADVANCED: Nuevas aproximaciones para el diagnóstico de cáncer de endometrio
Principal Investigator: Antonio Gil Moreno
Agency: Ministerio de Ciencia e Innovación. Retos en Colaboración Público Privada (CPP2021-00844)
Funding: 1,487,545.57 € (VHIR 369,335.50€)
Period: 2022-2024
Estrategia dual de biopsia líquida en cáncer de endometrio: evaluación del riesgo de recurrencia y terapias personalizadas
Principal Investigator: Antonio Gil Moreno and Miguel Abal Posada
Agency: Instituto de Salud Carlos III. Fondo de Investigación Sanitaria (Coordinado) PI20/01566
Funding: 209,330 €
Period: 2021-2023
CytoMARK: Development of a personalised non-invasive diagnosis of endometrial cancer using proteomic markers in cervical fluids and clinical data
Principal Investigator: Eva Colás Ortega (European project coordinator)
Agency: ERA-Net Cofund. JTC 2021. European Comission; Instituto de Salud Carlos III; Asociación Española Contra el Cáncer (ERAPERMED2021-146_CytoMARK)
Funding: 824,933 €
Period: 2022-2025
MiMARK
Principal Investigator: Eva Colás Ortega
Agency: Wild Card, Women Health edition. EiTHealth
Funding: 1,500,000 €
Period: 2021-2022
Targeting the most aggressive type of endometrial carcinoma
Principal Investigator: Antonio Gil Moreno
Agency: Asociacion Española Contra el Cancer. (AECC Grupos Estables - GCTRA1804MATI)
Funding: 1,000,000 € (VHIR 194,250 €)
Period: 2018-2024
Biomarkers for endometrial cancer Spain
Priority Number: EP21382680.3
Priority Date: 23/07/2021
Applicants: 100% VHIR
Markers for endometrial cancer. Licensed to MiMARK Diagnostics S.L in 2021 Spain
Priority Number: PCT/EP2018/069841
Priority Date: 21/07/2017
Applicants: 80% VHIR, 20% LIH
Markers of endometrial cancer. Licensed to MiMARK Diagnostics S.L in 2021 Spain
Priority Number: PCT/EP2017/057635
Priority Date: 04/05/2016
Applicants: 80% VHIR, 20% LIH